血必净第六次纳入新冠肺炎诊疗方案中药配方颗粒高增长红日药业业绩创新高 - Sina.cn

3/17/2022 12:00:00 AM3 years 1 month ago
by 21世纪经济报道

血必净第六次纳入新冠肺炎诊疗方案 中药配方颗粒高增长红日药业业绩创新高

300026.SZ 317 31721 7.54% IPO 317 2120042844.5%9.8% 31720214.147.54% 20091.0446.4348.4% 10 20190201083749202196.26% 21 FDA 302 202029.9146.09%20211849.56%51.64% 20105000 20212021 202… [+112 chars]

full article...